Építés alatt – nem éles oldal
Belépés
Toborzás még nem indultFázis nélkül

Cerebellar Research in Ultrasound Stimulation

A legfontosabb adatok

Ki végzi
KU Leuven
Hol
Belgium1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
60 fő, tervezett
Kezdés
2026. jún. 1.
Várható befejezés
2028. okt. 1.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • Transcranial focused ultrasound delivered to the dentate nucleus using the NeuroFUS Pro by Brainbox
  • Transcranial focused ultrasound delivered to the ventricles (control) using the NeuroFUS Pro by Brainbox
A regiszteradat frissítve
2026. április 2.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for healthy volunteers (Experiment 1) and people with essential tremor (Experiment 2). Both groups will get focused ultrasound stimulation of a brain area called the dentate nucleus.

Életkor
Healthy volunteers: 18-55 years. People with essential tremor: 18-75 years.
Nem
Men and women can join.
A betegség stádiuma
Healthy volunteers must be in good health. People with essential tremor must have the diagnosis confirmed by a movement disorder neurologist.
Korábbi kezelés
People with essential tremor cannot join if they have had a thalamotomy (surgery on the thalamus). No one can join while taking psychotropic medication (medicines that act on the mind).

A részvétel fő kizáró okai

  • Pregnancy
  • Own or family history of seizures or epilepsy
  • Metal in the body or implanted devices that cannot go in an MRI scanner
  • Serious mental illness, current psychiatric treatment, or head injury with loss of consciousness
  • Hair in dreadlocks, braids or weave, or forearm or hand bone and joint problems

A regiszter feltételei, szó szerint

Mind a 4 feltétel megnézéseKevesebb

Ki vehet részt

  • Experiment 1: Healthy Volunteers; Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures; Participants aged 18-55 years; Male of female; Good health with no history of serious mental illness or implanted metal; Willingness to adhere to the TUS and MRI study schedule; Willingness to avoid caffeine and alcohol intake for at least 2 h prior to the investigation
  • Experiment 2: ET Patients; Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures; Participants aged 18-75 years; Male of female; Diagnosis of ET as confirmed from clinical history and examination by a movement disorder neurologist; Willingness to adhere to the TUS and MRI study schedule; Willingness to avoid caffeine and alcohol intake for at least 2 h prior to the investigation

Ki nem vehet részt

  • Experiment 1: Healthy volunteers; Currently taking any psychotropic medication; Any head trauma resulting in loss of consciousness; Diagnosed with a serious mental illness; Alcohol or substance abuse or dependence (other than tobacco) in the past week; Currently in treatment for a psychiatric condition; Pregnancy (a test will be scheduled by the research team); Personal or family history of seizures or epilepsy; Claustrophobia or inability to stay still in the MR scanner environment; Any metal in the body that is not MRI-compatible; Serious history of migraines; Hair in dreadlocks, braids, or weave (not possible to position ultrasound transducer); orthopedic forearm or hand problems; Inability to adhere to the experimental schedule
  • Experiment 2: ET Patients; Currently taking any psychotropic medication; Implanted with a non-MRI compatible medical device; History of thalamotomy; Skin lesions at stimulation site; Peripheral neuropathy; neurologic exam not consistent with ET; Any head trauma resulting in loss of consciousness; Diagnosed with a serious mental illness; Alcohol or substance abuse or dependence (other than tobacco) in the past week; alcohol or caffeine consumption within 12 hours of study enrollment; Currently in treatment for a psychiatric condition; Pregnancy (scheduled test); Personal or family history of seizures or epilepsy; Claustrophobia or inability to stay still in the MR scanner environment; Any metal in the body that is not MRI-compatible; Serious history of migraines; Hair in dreadlocks, braids, or weave; orthopedic forearm or hand problems; Inability to adhere to the experimental schedule

Nézd meg, megfelelhetsz-e

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 75 év között vagy?

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Experiment 1: Modulation of Physiological Tremor in Healthy Volunteers Thirty healthy volunteers will undergo TUS targeting the dentate nucleus in a randomized, double-blinded crossover design. Tremor amplitude, induced by a 15 g weight, will be measured using an accelerometer, and EEG will assess neural oscillations and cerebello-thalamo-cortical connectivity.

A teljes eredeti leírásKevesebb

Stimulation will include short-term (1 minute on/off for 12 minutes) and long-term (30 minutes) protocols, as well as closed-loop TUS for phase-specific effects. This experiment aims to optimize stimulation parameters and explore the dentate nucleus's role in tremor generation.

Experiment 2: Tremor Modulation in Essential Tremor Patients Thirty ET patients will receive TUS targeting the dentate nucleus with optimized parameters from Experiment 1 in a randomized crossover design. The best protocol from previous experiment will be tested here. Tremor amplitude and EEG will be recorded to assess short- and long-term effects of TUS on pathological tremor.

A vizsgálat 2 csoportja

  • On-target to shamA vizsgált kezelés

    Participants in this arm will receive on-target stimulation first, followed by the sham condition

    Kezelés: Transcranial focused ultrasound delivered to the dentate nucleus using the NeuroFUS Pro by Brainbox és Transcranial focused ultrasound delivered to the ventricles (control) using the NeuroFUS Pro by Brainbox

  • Sham to on-targetA vizsgált kezelés

    Participants in this arm will receive sham stimulation first, followed by the on-target stimulation

    Kezelés: Transcranial focused ultrasound delivered to the dentate nucleus using the NeuroFUS Pro by Brainbox és Transcranial focused ultrasound delivered to the ventricles (control) using the NeuroFUS Pro by Brainbox

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Illeszkedési kérdések
Forrás: NCT07508696: ki vehet részt
A regiszteradat frissítve
2026. április 2.
Építés alatt, nem éles – Cerebellar Research in Ultrasound Stimulation (NCT07508696) – Frontlight Research